A uniquely positive, self-described patient experience with the R-MAOI Moclobemide, prescribed for treatment-resistant-depression-anxiety.
(2024)
Journal Article
ADAMS, N.N. 2024. A uniquely positive, self-described patient experience with the R-MAOI Moclobemide, prescribed for treatment-resistant-depression-anxiety. Psychiatry research [online], 337, article number 115924. Available from: https://doi.org/10.1016/j.psychres.2024.115924
Treatment-resistant clinical depression and linked-anxiety represents a serious debilitating illness. Individual presentation differs. Symptoms can be co-occurring depressive-state and high-anxiety [1], [2]. My own longitudinal experiences with depre... Read More about A uniquely positive, self-described patient experience with the R-MAOI Moclobemide, prescribed for treatment-resistant-depression-anxiety..